1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Oncology Treatment Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Chemotherapy 1.2.3 Targeted Therapy 1.2.4 Immunotherapy (Biologic Therapy) 1.2.5 Hormonal Therapy 1.2.6 Others 1.3 Market by Application 1.3.1 Global Oncology Treatment Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Blood Cancer 1.3.3 Breast Cancer 1.3.4 Gastrointestinal Cancer 1.3.5 Prostate Cancer 1.3.6 Respiratory/Lung Cancer 1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Oncology Treatment Drug Market Perspective (2016-2027) 2.2 Oncology Treatment Drug Growth Trends by Regions 2.2.1 Oncology Treatment Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Oncology Treatment Drug Historic Market Share by Regions (2016-2021) 2.2.3 Oncology Treatment Drug Forecasted Market Size by Regions (2022-2027) 2.3 Oncology Treatment Drug Industry Dynamic 2.3.1 Oncology Treatment Drug Market Trends 2.3.2 Oncology Treatment Drug Market Drivers 2.3.3 Oncology Treatment Drug Market Challenges 2.3.4 Oncology Treatment Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Oncology Treatment Drug Players by Revenue 3.1.1 Global Top Oncology Treatment Drug Players by Revenue (2016-2021) 3.1.2 Global Oncology Treatment Drug Revenue Market Share by Players (2016-2021) 3.2 Global Oncology Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Oncology Treatment Drug Revenue 3.4 Global Oncology Treatment Drug Market Concentration Ratio 3.4.1 Global Oncology Treatment Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Oncology Treatment Drug Revenue in 2020 3.5 Oncology Treatment Drug Key Players Head office and Area Served 3.6 Key Players Oncology Treatment Drug Product Solution and Service 3.7 Date of Enter into Oncology Treatment Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Oncology Treatment Drug Breakdown Data by Type 4.1 Global Oncology Treatment Drug Historic Market Size by Type (2016-2021) 4.2 Global Oncology Treatment Drug Forecasted Market Size by Type (2022-2027) 5 Oncology Treatment Drug Breakdown Data by Application 5.1 Global Oncology Treatment Drug Historic Market Size by Application (2016-2021) 5.2 Global Oncology Treatment Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Oncology Treatment Drug Market Size (2016-2027) 6.2 North America Oncology Treatment Drug Market Size by Type 6.2.1 North America Oncology Treatment Drug Market Size by Type (2016-2021) 6.2.2 North America Oncology Treatment Drug Market Size by Type (2022-2027) 6.2.3 North America Oncology Treatment Drug Market Size by Type (2016-2027) 6.3 North America Oncology Treatment Drug Market Size by Application 6.3.1 North America Oncology Treatment Drug Market Size by Application (2016-2021) 6.3.2 North America Oncology Treatment Drug Market Size by Application (2022-2027) 6.3.3 North America Oncology Treatment Drug Market Size by Application (2016-2027) 6.4 North America Oncology Treatment Drug Market Size by Country 6.4.1 North America Oncology Treatment Drug Market Size by Country (2016-2021) 6.4.2 North America Oncology Treatment Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Oncology Treatment Drug Market Size (2016-2027) 7.2 Europe Oncology Treatment Drug Market Size by Type 7.2.1 Europe Oncology Treatment Drug Market Size by Type (2016-2021) 7.2.2 Europe Oncology Treatment Drug Market Size by Type (2022-2027) 7.2.3 Europe Oncology Treatment Drug Market Size by Type (2016-2027) 7.3 Europe Oncology Treatment Drug Market Size by Application 7.3.1 Europe Oncology Treatment Drug Market Size by Application (2016-2021) 7.3.2 Europe Oncology Treatment Drug Market Size by Application (2022-2027) 7.3.3 Europe Oncology Treatment Drug Market Size by Application (2016-2027) 7.4 Europe Oncology Treatment Drug Market Size by Country 7.4.1 Europe Oncology Treatment Drug Market Size by Country (2016-2021) 7.4.2 Europe Oncology Treatment Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Oncology Treatment Drug Market Size (2016-2027) 8.2 Asia-Pacific Oncology Treatment Drug Market Size by Type 8.2.1 Asia-Pacific Oncology Treatment Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Oncology Treatment Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Oncology Treatment Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Oncology Treatment Drug Market Size by Application 8.3.1 Asia-Pacific Oncology Treatment Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Oncology Treatment Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Oncology Treatment Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Oncology Treatment Drug Market Size by Region 8.4.1 Asia-Pacific Oncology Treatment Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Oncology Treatment Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Oncology Treatment Drug Market Size (2016-2027) 9.2 Latin America Oncology Treatment Drug Market Size by Type 9.2.1 Latin America Oncology Treatment Drug Market Size by Type (2016-2021) 9.2.2 Latin America Oncology Treatment Drug Market Size by Type (2022-2027) 9.2.3 Latin America Oncology Treatment Drug Market Size by Type (2016-2027) 9.3 Latin America Oncology Treatment Drug Market Size by Application 9.3.1 Latin America Oncology Treatment Drug Market Size by Application (2016-2021) 9.3.2 Latin America Oncology Treatment Drug Market Size by Application (2022-2027) 9.3.3 Latin America Oncology Treatment Drug Market Size by Application (2016-2027) 9.4 Latin America Oncology Treatment Drug Market Size by Country 9.4.1 Latin America Oncology Treatment Drug Market Size by Country (2016-2021) 9.4.2 Latin America Oncology Treatment Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Oncology Treatment Drug Market Size (2016-2027) 10.2 Middle East & Africa Oncology Treatment Drug Market Size by Type 10.2.1 Middle East & Africa Oncology Treatment Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Oncology Treatment Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Oncology Treatment Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Oncology Treatment Drug Market Size by Application 10.3.1 Middle East & Africa Oncology Treatment Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Oncology Treatment Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Oncology Treatment Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Oncology Treatment Drug Market Size by Country 10.4.1 Middle East & Africa Oncology Treatment Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Oncology Treatment Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview 11.1.3 Roche Oncology Treatment Drug Introduction 11.1.4 Roche Revenue in Oncology Treatment Drug Business (2016-2021) 11.1.5 Roche Recent Development 11.2 Celgene 11.2.1 Celgene Company Details 11.2.2 Celgene Business Overview 11.2.3 Celgene Oncology Treatment Drug Introduction 11.2.4 Celgene Revenue in Oncology Treatment Drug Business (2016-2021) 11.2.5 Celgene Recent Development 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Novartis Business Overview 11.3.3 Novartis Oncology Treatment Drug Introduction 11.3.4 Novartis Revenue in Oncology Treatment Drug Business (2016-2021) 11.3.5 Novartis Recent Development 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Company Details 11.4.2 Bristol-Myers Squibb Business Overview 11.4.3 Bristol-Myers Squibb Oncology Treatment Drug Introduction 11.4.4 Bristol-Myers Squibb Revenue in Oncology Treatment Drug Business (2016-2021) 11.4.5 Bristol-Myers Squibb Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Oncology Treatment Drug Introduction 11.5.4 Johnson & Johnson Revenue in Oncology Treatment Drug Business (2016-2021) 11.5.5 Johnson & Johnson Recent Development 11.6 Merck & Co. 11.6.1 Merck & Co. Company Details 11.6.2 Merck & Co. Business Overview 11.6.3 Merck & Co. Oncology Treatment Drug Introduction 11.6.4 Merck & Co. Revenue in Oncology Treatment Drug Business (2016-2021) 11.6.5 Merck & Co. Recent Development 11.7 AstraZeneca 11.7.1 AstraZeneca Company Details 11.7.2 AstraZeneca Business Overview 11.7.3 AstraZeneca Oncology Treatment Drug Introduction 11.7.4 AstraZeneca Revenue in Oncology Treatment Drug Business (2016-2021) 11.7.5 AstraZeneca Recent Development 11.8 Pfizer 11.8.1 Pfizer Company Details 11.8.2 Pfizer Business Overview 11.8.3 Pfizer Oncology Treatment Drug Introduction 11.8.4 Pfizer Revenue in Oncology Treatment Drug Business (2016-2021) 11.8.5 Pfizer Recent Development 11.9 Amgen 11.9.1 Amgen Company Details 11.9.2 Amgen Business Overview 11.9.3 Amgen Oncology Treatment Drug Introduction 11.9.4 Amgen Revenue in Oncology Treatment Drug Business (2016-2021) 11.9.5 Amgen Recent Development 11.10 Eli Lilly 11.10.1 Eli Lilly Company Details 11.10.2 Eli Lilly Business Overview 11.10.3 Eli Lilly Oncology Treatment Drug Introduction 11.10.4 Eli Lilly Revenue in Oncology Treatment Drug Business (2016-2021) 11.10.5 Eli Lilly Recent Development 11.11 AbbVie 11.11.1 AbbVie Company Details 11.11.2 AbbVie Business Overview 11.11.3 AbbVie Oncology Treatment Drug Introduction 11.11.4 AbbVie Revenue in Oncology Treatment Drug Business (2016-2021) 11.11.5 AbbVie Recent Development 11.12 Takeda 11.12.1 Takeda Company Details 11.12.2 Takeda Business Overview 11.12.3 Takeda Oncology Treatment Drug Introduction 11.12.4 Takeda Revenue in Oncology Treatment Drug Business (2016-2021) 11.12.5 Takeda Recent Development 11.13 Astellas 11.13.1 Astellas Company Details 11.13.2 Astellas Business Overview 11.13.3 Astellas Oncology Treatment Drug Introduction 11.13.4 Astellas Revenue in Oncology Treatment Drug Business (2016-2021) 11.13.5 Astellas Recent Development 11.14 Ipsen 11.14.1 Ipsen Company Details 11.14.2 Ipsen Business Overview 11.14.3 Ipsen Oncology Treatment Drug Introduction 11.14.4 Ipsen Revenue in Oncology Treatment Drug Business (2016-2021) 11.14.5 Ipsen Recent Development 11.15 Sanofi 11.15.1 Sanofi Company Details 11.15.2 Sanofi Business Overview 11.15.3 Sanofi Oncology Treatment Drug Introduction 11.15.4 Sanofi Revenue in Oncology Treatment Drug Business (2016-2021) 11.15.5 Sanofi Recent Development 11.16 Bayer 11.16.1 Bayer Company Details 11.16.2 Bayer Business Overview 11.16.3 Bayer Oncology Treatment Drug Introduction 11.16.4 Bayer Revenue in Oncology Treatment Drug Business (2016-2021) 11.16.5 Bayer Recent Development 11.17 Biogen Idec 11.17.1 Biogen Idec Company Details 11.17.2 Biogen Idec Business Overview 11.17.3 Biogen Idec Oncology Treatment Drug Introduction 11.17.4 Biogen Idec Revenue in Oncology Treatment Drug Business (2016-2021) 11.17.5 Biogen Idec Recent Development 11.18 Teva 11.18.1 Teva Company Details 11.18.2 Teva Business Overview 11.18.3 Teva Oncology Treatment Drug Introduction 11.18.4 Teva Revenue in Oncology Treatment Drug Business (2016-2021) 11.18.5 Teva Recent Development 11.18 Otsuka .1 Otsuka Company Details .2 Otsuka Business Overview .3 Otsuka Oncology Treatment Drug Introduction .4 Otsuka Revenue in Oncology Treatment Drug Business (2016-2021) .5 Otsuka Recent Development 11.20 Eisai 11.20.1 Eisai Company Details 11.20.2 Eisai Business Overview 11.20.3 Eisai Oncology Treatment Drug Introduction 11.20.4 Eisai Revenue in Oncology Treatment Drug Business (2016-2021) 11.20.5 Eisai Recent Development 11.21 Merck KGaA 11.21.1 Merck KGaA Company Details 11.21.2 Merck KGaA Business Overview 11.21.3 Merck KGaA Oncology Treatment Drug Introduction 11.21.4 Merck KGaA Revenue in Oncology Treatment Drug Business (2016-2021) 11.21.5 Merck KGaA Recent Development 11.22 Gilead Sciences 11.22.1 Gilead Sciences Company Details 11.22.2 Gilead Sciences Business Overview 11.22.3 Gilead Sciences Oncology Treatment Drug Introduction 11.22.4 Gilead Sciences Revenue in Oncology Treatment Drug Business (2016-2021) 11.22.5 Gilead Sciences Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Oncology Treatment Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Chemotherapy Table 3. Key Players of Targeted Therapy Table 4. Key Players of Immunotherapy (Biologic Therapy) Table 5. Key Players of Hormonal Therapy Table 6. Key Players of Others Table 7. Global Oncology Treatment Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Oncology Treatment Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Oncology Treatment Drug Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Oncology Treatment Drug Market Share by Regions (2016-2021) Table 11. Global Oncology Treatment Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Oncology Treatment Drug Market Share by Regions (2022-2027) Table 13. Oncology Treatment Drug Market Trends Table 14. Oncology Treatment Drug Market Drivers Table 15. Oncology Treatment Drug Market Challenges Table 16. Oncology Treatment Drug Market Restraints Table 17. Global Oncology Treatment Drug Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Oncology Treatment Drug Market Share by Players (2016-2021) Table 19. Global Top Oncology Treatment Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Treatment Drug as of 2020) Table 20. Ranking of Global Top Oncology Treatment Drug Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Oncology Treatment Drug Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Oncology Treatment Drug Product Solution and Service Table 24. Date of Enter into Oncology Treatment Drug Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Oncology Treatment Drug Market Size by Type (2016-2021) (US$ Million) Table 27. Global Oncology Treatment Drug Revenue Market Share by Type (2016-2021) Table 28. Global Oncology Treatment Drug Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Oncology Treatment Drug Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Oncology Treatment Drug Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Oncology Treatment Drug Revenue Market Share by Application (2016-2021) Table 32. Global Oncology Treatment Drug Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Oncology Treatment Drug Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Oncology Treatment Drug Market Size by Type (2016-2021) (US$ Million) Table 35. North America Oncology Treatment Drug Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Oncology Treatment Drug Market Size by Application (2016-2021) (US$ Million) Table 37. North America Oncology Treatment Drug Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Oncology Treatment Drug Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Oncology Treatment Drug Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Oncology Treatment Drug Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Oncology Treatment Drug Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Oncology Treatment Drug Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Oncology Treatment Drug Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Oncology Treatment Drug Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Oncology Treatment Drug Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Oncology Treatment Drug Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Oncology Treatment Drug Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Oncology Treatment Drug Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Oncology Treatment Drug Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Oncology Treatment Drug Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Oncology Treatment Drug Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Oncology Treatment Drug Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Oncology Treatment Drug Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Oncology Treatment Drug Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Oncology Treatment Drug Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Oncology Treatment Drug Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Oncology Treatment Drug Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Oncology Treatment Drug Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Oncology Treatment Drug Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Oncology Treatment Drug Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Oncology Treatment Drug Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Oncology Treatment Drug Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Oncology Treatment Drug Market Size by Country (2022-2027) & (US$ Million) Table 64. Roche Company Details Table 65. Roche Business Overview Table 66. Roche Oncology Treatment Drug Product Table 67. Roche Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 68. Roche Recent Development Table 69. Celgene Company Details Table 70. Celgene Business Overview Table 71. Celgene Oncology Treatment Drug Product Table 72. Celgene Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 73. Celgene Recent Development Table 74. Novartis Company Details Table 75. Novartis Business Overview Table 76. Novartis Oncology Treatment Drug Product Table 77. Novartis Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 78. Novartis Recent Development Table 79. Bristol-Myers Squibb Company Details Table 80. Bristol-Myers Squibb Business Overview Table 81. Bristol-Myers Squibb Oncology Treatment Drug Product Table 82. Bristol-Myers Squibb Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 83. Bristol-Myers Squibb Recent Development Table 84. Johnson & Johnson Company Details Table 85. Johnson & Johnson Business Overview Table 86. Johnson & Johnson Oncology Treatment Drug Product Table 87. Johnson & Johnson Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 88. Johnson & Johnson Recent Development Table 89. Merck & Co. Company Details Table 90. Merck & Co. Business Overview Table 91. Merck & Co. Oncology Treatment Drug Product Table 92. Merck & Co. Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 93. Merck & Co. Recent Development Table 94. AstraZeneca Company Details Table 95. AstraZeneca Business Overview Table 96. AstraZeneca Oncology Treatment Drug Product Table 97. AstraZeneca Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 98. AstraZeneca Recent Development Table 99. Pfizer Company Details Table 100. Pfizer Business Overview Table 101. Pfizer Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 102. Pfizer Recent Development Table 103. Amgen Company Details Table 104. Amgen Business Overview Table 105. Amgen Oncology Treatment Drug Product Table 106. Amgen Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 107. Amgen Recent Development Table 108. Eli Lilly Company Details Table 109. Eli Lilly Business Overview Table 110. Eli Lilly Oncology Treatment Drug Product Table 111. Eli Lilly Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 112. Eli Lilly Recent Development Table 113. AbbVie Company Details Table 114. AbbVie Business Overview Table 115. AbbVie Oncology Treatment Drug Product Table 116. AbbVie Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 117. AbbVie Recent Development Table 118. Takeda Company Details Table 119. Takeda Business Overview Table 120. Takeda Oncology Treatment Drug Product Table 121. Takeda Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 122. Takeda Recent Development Table 123. Astellas Company Details Table 124. Astellas Business Overview Table 125. Astellas Oncology Treatment Drug Product Table 126. Astellas Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 127. Astellas Recent Development Table 128. Ipsen Company Details Table 129. Ipsen Business Overview Table 130. Ipsen Oncology Treatment Drug Product Table 131. Ipsen Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 132. Ipsen Recent Development Table 133. Sanofi Company Details Table 134. Sanofi Business Overview Table 135. Sanofi Oncology Treatment Drug Product Table 136. Sanofi Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 137. Sanofi Recent Development Table 138. Bayer Company Details Table 139. Bayer Business Overview Table 140. Bayer Oncology Treatment Drug Product Table 141. Bayer Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 142. Bayer Recent Development Table 143. Biogen Idec Company Details Table 144. Biogen Idec Business Overview Table 145. Biogen Idec Oncology Treatment Drug Product Table 146. Biogen Idec Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 147. Biogen Idec Recent Development Table 148. Teva Company Details Table 149. Teva Business Overview Table 150. Teva Oncology Treatment Drug Product Table 151. Teva Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 152. Teva Recent Development Table 153. Otsuka Company Details Table 154. Otsuka Business Overview Table 155. Otsuka Oncology Treatment Drug Product Table 156. Otsuka Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 157. Otsuka Recent Development Table 158. Eisai Company Details Table 159. Eisai Business Overview Table 160. Eisai Oncology Treatment Drug Product Table 161. Eisai Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 162. Eisai Recent Development Table 163. Merck KGaA Company Details Table 164. Merck KGaA Business Overview Table 165. Merck KGaA Oncology Treatment Drug Product Table 166. Merck KGaA Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 167. Merck KGaA Recent Development Table 168. Gilead Sciences Company Details Table 169. Gilead Sciences Business Overview Table 170. Gilead Sciences Oncology Treatment Drug Product Table 171. Gilead Sciences Revenue in Oncology Treatment Drug Business (2016-2021) & (US$ Million) Table 172. Gilead Sciences Recent Development Table 173. Research Programs/Design for This Report Table 174. Key Data Information from Secondary Sources Table 175. Key Data Information from Primary Sources List of Figures Figure 1. Global Oncology Treatment Drug Market Share by Type: 2020 VS 2027 Figure 2. Chemotherapy Features Figure 3. Targeted Therapy Features Figure 4. Immunotherapy (Biologic Therapy) Features Figure 5. Hormonal Therapy Features Figure 6. Others Features Figure 7. Global Oncology Treatment Drug Market Share by Application: 2020 VS 2027 Figure 8. Blood Cancer Case Studies Figure 9. Breast Cancer Case Studies Figure 10. Gastrointestinal Cancer Case Studies Figure 11. Prostate Cancer Case Studies Figure 12. Respiratory/Lung Cancer Case Studies Figure 13. Others Case Studies Figure 14. Oncology Treatment Drug Report Years Considered Figure 15. Global Oncology Treatment Drug Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 16. Global Oncology Treatment Drug Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 17. Global Oncology Treatment Drug Market Share by Regions: 2020 VS 2027 Figure 18. Global Oncology Treatment Drug Market Share by Regions (2022-2027) Figure 19. Global Oncology Treatment Drug Market Share by Players in 2020 Figure 20. Global Top Oncology Treatment Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Treatment Drug as of 2020 Figure 21. The Top 10 and 5 Players Market Share by Oncology Treatment Drug Revenue in 2020 Figure 22. Global Oncology Treatment Drug Revenue Market Share by Type (2016-2021) Figure 23. Global Oncology Treatment Drug Revenue Market Share by Type (2022-2027) Figure 24. North America Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. North America Oncology Treatment Drug Market Share by Type (2016-2027) Figure 26. North America Oncology Treatment Drug Market Share by Application (2016-2027) Figure 27. North America Oncology Treatment Drug Market Share by Country (2016-2027) Figure 28. United States Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Canada Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe Oncology Treatment Drug Market Share by Type (2016-2027) Figure 32. Europe Oncology Treatment Drug Market Share by Application (2016-2027) Figure 33. Europe Oncology Treatment Drug Market Share by Country (2016-2027) Figure 34. Germany Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. France Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. U.K. Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Italy Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Russia Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Nordic Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific Oncology Treatment Drug Market Share by Type (2016-2027) Figure 42. Asia-Pacific Oncology Treatment Drug Market Share by Application (2016-2027) Figure 43. Asia-Pacific Oncology Treatment Drug Market Share by Region (2016-2027) Figure 44. China Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Japan Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. South Korea Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Southeast Asia Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. India Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Australia Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America Oncology Treatment Drug Market Share by Type (2016-2027) Figure 52. Latin America Oncology Treatment Drug Market Share by Application (2016-2027) Figure 53. Latin America Oncology Treatment Drug Market Share by Country (2016-2027) Figure 54. Mexico Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Brazil Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa Oncology Treatment Drug Market Share by Type (2016-2027) Figure 58. Middle East & Africa Oncology Treatment Drug Market Share by Application (2016-2027) Figure 59. Middle East & Africa Oncology Treatment Drug Market Share by Country (2016-2027) Figure 60. Turkey Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Saudi Arabia Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. UAE Oncology Treatment Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. Roche Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 64. Celgene Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 65. Novartis Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 67. Johnson & Johnson Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 68. Merck & Co. Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 69. AstraZeneca Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 70. Pfizer Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 71. Amgen Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 72. Eli Lilly Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 73. AbbVie Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 74. Takeda Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 75. Astellas Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 76. Ipsen Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 77. Sanofi Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 78. Bayer Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 79. Biogen Idec Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 80. Teva Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 81. Otsuka Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 82. Eisai Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 83. Merck KGaA Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 84. Gilead Sciences Revenue Growth Rate in Oncology Treatment Drug Business (2016-2021) Figure 85. Bottom-up and Top-down Approaches for This Report Figure 86. Data Triangulation Figure 87. Key Executives Interviewed

Roche Celgene Novartis Bristol-Myers Squibb Johnson & Johnson Merck & Co. AstraZeneca Pfizer Amgen Eli Lilly AbbVie Takeda Astellas Ipsen Sanofi Bayer Biogen Idec Teva Otsuka Eisai Merck KGaA Gilead Sciences